Fresenius Kabi USA Unclassified
FDA Approved Drugs

Fresenius Kabi USA Unclassified

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Unclassified
  • Total Records 18
  • Latest Approval Date -
  • Data Source FDA
  • First Approval Date -
All
581
View
Unclassified
18
View
Discontinued
146
View
RX
417
View
Company Overview

Company

Fresenius Kabi USA Unclassified

Country

U.S.A

Social Profiles

Company Snapshot

Fresenius Kabi USA Unclassified

Three Corporate DriveLake Zurich, Illinois 60047

U.S.A

www.fresenius-kabi.com/us/ contactus@fresenius-kabi.com View on Map
FDA Approved Drug Records ( 18 records )
-
Unclassified Application: 210410

Drug Name

BENDAMUSTINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

100MG/4ML (25MG/ML)

Approval Date

-

210410 / 1

Active Ingredient

BENDAMUSTINE HYDROCHLORIDE

Application Number

210410

Product Number

1

Dosage Form

-

Strength

100MG/4ML (25MG/ML)

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 207937

Drug Name

CABAZITAXEL

Product Number

1

Dosage Form

-

Strength

20MG/ML

Approval Date

-

207937 / 1

Active Ingredient

CABAZITAXEL

Application Number

207937

Product Number

1

Dosage Form

-

Strength

20MG/ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 17067

Drug Name

CHORIONIC GONADOTROPIN

Product Number

1

Dosage Form

-

Strength

5,000 UNITS/VIAL

Approval Date

-

17067 / 1

Active Ingredient

GONADOTROPIN, CHORIONIC

Application Number

17067

Product Number

1

Dosage Form

-

Strength

5,000 UNITS/VIAL

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 17067

Drug Name

CHORIONIC GONADOTROPIN

Product Number

2

Dosage Form

-

Strength

10,000 UNITS/VIAL

Approval Date

-

17067 / 2

Active Ingredient

GONADOTROPIN, CHORIONIC

Application Number

17067

Product Number

2

Dosage Form

-

Strength

10,000 UNITS/VIAL

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 17067

Drug Name

CHORIONIC GONADOTROPIN

Product Number

3

Dosage Form

-

Strength

20,000 UNITS/VIAL

Approval Date

-

17067 / 3

Active Ingredient

GONADOTROPIN, CHORIONIC

Application Number

17067

Product Number

3

Dosage Form

-

Strength

20,000 UNITS/VIAL

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 17067

Drug Name

CHORIONIC GONADOTROPIN

Product Number

4

Dosage Form

-

Strength

15,000 UNITS/VIAL

Approval Date

-

17067 / 4

Active Ingredient

GONADOTROPIN, CHORIONIC

Application Number

17067

Product Number

4

Dosage Form

-

Strength

15,000 UNITS/VIAL

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 208129

Drug Name

DEXMEDETOMIDINE HYDROCHLORIDE

Product Number

4

Dosage Form

-

Strength

EQ 80MCG BASE/20ML (EQ 4MCG BASE/ML)

Approval Date

-

208129 / 4

Active Ingredient

DEXMEDETOMIDINE HYDROCHLORIDE

Application Number

208129

Product Number

4

Dosage Form

-

Strength

EQ 80MCG BASE/20ML (EQ 4MCG BASE/ML)

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 90242

Drug Name

GEMCITABINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 200MG BASE/VIAL

Approval Date

-

90242 / 1

Active Ingredient

GEMCITABINE HYDROCHLORIDE

Application Number

90242

Product Number

1

Dosage Form

-

Strength

EQ 200MG BASE/VIAL

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 90242

Drug Name

GEMCITABINE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 1GM BASE/VIAL

Approval Date

-

90242 / 2

Active Ingredient

GEMCITABINE HYDROCHLORIDE

Application Number

90242

Product Number

2

Dosage Form

-

Strength

EQ 1GM BASE/VIAL

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 761255

Drug Name

IDACIO

Product Number

1

Dosage Form

-

Strength

40MG/0.8ML

Approval Date

-

761255 / 1

Active Ingredient

ADALIMUMAB-AACF

Application Number

761255

Product Number

1

Dosage Form

-

Strength

40MG/0.8ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 761379

Drug Name

OTULFI

Product Number

1

Dosage Form

-

Strength

45MG/0.5ML

Approval Date

-

761379 / 1

Active Ingredient

USTEKINUMAB-AAUZ

Application Number

761379

Product Number

1

Dosage Form

-

Strength

45MG/0.5ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 761379

Drug Name

OTULFI

Product Number

2

Dosage Form

-

Strength

90MG/1ML

Approval Date

-

761379 / 2

Active Ingredient

USTEKINUMAB-AAUZ

Application Number

761379

Product Number

2

Dosage Form

-

Strength

90MG/1ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 761379

Drug Name

OTULFI

Product Number

3

Dosage Form

-

Strength

130MG/26ML

Approval Date

-

761379 / 3

Active Ingredient

USTEKINUMAB-AAUZ

Application Number

761379

Product Number

3

Dosage Form

-

Strength

130MG/26ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 761173

Drug Name

STIMUFEND

Product Number

1

Dosage Form

-

Strength

6MG/0.6ML

Approval Date

-

761173 / 1

Active Ingredient

PEGFILGRASTIM-FPGK

Application Number

761173

Product Number

1

Dosage Form

-

Strength

6MG/0.6ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 761275

Drug Name

TYENNE

Product Number

2

Dosage Form

-

Strength

80MG/4ML

Approval Date

-

761275 / 2

Active Ingredient

TOCILIZUMAB-AAZG

Application Number

761275

Product Number

2

Dosage Form

-

Strength

80MG/4ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 761275

Drug Name

TYENNE

Product Number

3

Dosage Form

-

Strength

200MG/10ML

Approval Date

-

761275 / 3

Active Ingredient

TOCILIZUMAB-AAZG

Application Number

761275

Product Number

3

Dosage Form

-

Strength

200MG/10ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 761275

Drug Name

TYENNE

Product Number

4

Dosage Form

-

Strength

400MG/20ML

Approval Date

-

761275 / 4

Active Ingredient

TOCILIZUMAB-AAZG

Application Number

761275

Product Number

4

Dosage Form

-

Strength

400MG/20ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 761449

Drug Name

TYENNE

Product Number

4

Dosage Form

-

Strength

162MG/0.9ML

Approval Date

-

761449 / 4

Active Ingredient

TOCILIZUMAB-AAZG

Application Number

761449

Product Number

4

Dosage Form

-

Strength

162MG/0.9ML

Approval Date

-

Regulatory Status

Unclassified

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    581 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
18 total
  • Unclassified
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

BENDAMUSTINE HYDROCHLORIDE

Application Number

210410

Product Number

1

Active Ingredient

BENDAMUSTINE HYDROCHLORIDE

Dosage Form

-

Strength

100MG/4ML (25MG/ML)

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.